Recall Record

Crumlin (North), N/A, Ireland

Randox Laboratories Ltd. recalls

61 recalls recorded since 2018, most recently on 20 December 2024. 23 are listed as ongoing. Status and classification are as published by the FDA.

Recalls61
Ongoing (FDA)23
Terminated or completed38
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
20 December 2024
Reason
Lipoprotein (a) on Roche Cobas c501 with nmol/l claims does not have a 510(k) or PMA.
Distribution
US Nationwide distribution Including PR.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1018-2025, Z-1017-2025

Ongoing Class II Medical devices

Recall started
7 June 2024
Reason
Cystatin C Reagent marketed without a 510 (k)
Distribution
US Nationwide distribution in the states of AL, CA, GA, NY.
Initiated
Voluntary: Firm initiated
Recall number
Z-2425-2024

Ongoing Class III Medical devices

Recall started
5 April 2024
Reason
Foam gasket on the Evidence MultiSTAT chip heater assembly may not perform as expected. Foam that is not functioning as expected may cause light to leak into the Charged Coupled Device (CCD) Camera during imaging. This will affect the testing and may delay in reporting results.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1786-2024

Ongoing Class II Medical devices

Recall started
5 March 2024
Reason
Randox Laboratories has identified that Inorganic Phosphate in Calibration Serum Level 3, CAL2351 & CAL10388, is running with a negative bias on RX Series instruments compared to other methods.
Distribution
Domestic: Nationwide Distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1759-2024

Ongoing Class II Medical devices

Recall started
1 March 2024
Reason
The firm has realigned C3 and Haptoglobin in Liquid Protein Calibrators, IT2691, to reference material ERM-DA470k/IFCC.
Distribution
Domestic: CA, FL, IL, ME, NJ, OH, & OR.
Initiated
Voluntary: Firm initiated
Recall number
Z-1328-2024

Ongoing Class II Medical devices

Recall started
14 February 2024
Reason
Cystatin C Calibrator Series CVS 2699, is running with a negative bias compared to other methods
Distribution
US Nationwide distribution in the states of CA, IN.
Initiated
Voluntary: Firm initiated
Recall number
Z-1369-2024

Ongoing Class II Medical devices

Recall started
31 January 2024
Reason
Microalbumin Calibrator Series, MA1567 & MA2426, is running with a negative bias compared to other methods and may misclassify patient results. Users may experience a shift in Quality Control and patient sample recovery of up to +12%.
Distribution
US Nationwide distribution in the states of GA, MA, WV including PR.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1593-2024, Z-1594-2024

Ongoing Class II Medical devices

Recall started
29 November 2023
Reason
Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copper, should not be run directly after Total Protein, on the RX series instruments testing order. If copper assay is run after total protein it could lead to falsely elevated copper results.
Distribution
US Nationwide distribution in the states of SC and OK.
Initiated
Voluntary: Firm initiated
Recall number
Z-0992-2024

Ongoing Class II Medical devices

Recall started
20 November 2023
Reason
Target for Alkaline Phosphatase (ALP) for the AMP optimized to IFCC 37¿C method has been mis-assigned for the RX Series instruments by approximately 10% on Quality Control and patient samples
Distribution
US Nationwide including Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall number
Z-0753-2024

Ongoing Class II Medical devices

Recall started
20 November 2023
Reason
CK Total in Calibration Serum Level 3, CAL2351, is running with a positive bias on RX Series instruments compared to other methods experience a shift in Quality Control and patient sample recovery of up to 13%.
Distribution
US Nationwide and Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall number
Z-0752-2024

Ongoing Class II Medical devices

Recall started
13 November 2023
Reason
There have been transcription errors on the Instructions For Use (IFU) of the Calibration Serum Level 3 (CAL2351 lot 1260UE, 1262UE and 1315UE) for target values of Bilirubin and Triglycerides, on the IFU of Human Assayed Multi-Sera Level 2 (HN1530) for TBIC taget value and on IFU of Human Assayed Multi-Sera Level 3 (HE 1532) for Lipase target value.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0751-2024

Ongoing Class III Medical devices

Recall started
6 November 2023
Reason
A decrease in the reactivity of HSV Type 1/2 lgM in the Serology ToRCH lgM Positive Control when tested on the DiaSorin Liaison XL.
Distribution
NY, WV
Initiated
Voluntary: Firm initiated
Recall number
Z-0624-2024

Ongoing Class II Medical devices

Recall started
11 October 2023
Reason
Randox has had reports of elevated patient results using Plasma (lithium heparin) samples with Total Bilirubin reagent (TBil) Vanadate Oxidation Method.
Distribution
US Nationwide distribution in the states of AR, GA, NC, TN, & PR.
Initiated
Voluntary: Firm initiated
Recall number
Z-0501-2024

Ongoing Class II Medical devices

Recall started
6 September 2023
Reason
RX Parameter rerun settings (Sample Volume Low/High), and Dilutions used for Auto reruns, not meeting sample re-run conditions when samples are above or below assay range and may result i issues with the re-run feature conditions when incorrectly. Potential to report incorrectly.
Distribution
US Nationwide distribution including Puerto Rico
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0201-2024, Z-0202-2024, Z-0200-2024, Z-0198-2024, Z-0199-2024

Ongoing Class II Medical devices

Recall started
3 August 2023
Reason
there has been a transcription error in the Instructions for Use (IFU) for the Liquid Assayed Chemistry Control Premium Plus Level 3. For Caeruloplasmin, the one and two standard deviation values printed on the sheet are incorrect, which may lead to misreporting patient results. Target and range values are correct, and risk is mitigated; most clinical labs will use the target and range values in clinical practice.
Distribution
US States: GA, OH, OR, PA, TX, VA
Initiated
Voluntary: Firm initiated
Recall number
Z-2609-2023

Ongoing Class II Medical devices

Recall started
19 July 2023
Reason
As part of the firm's ongoing quality monitoring (see internal complaint # OCC72574), Randox Laboratories have restandardized Ferritin in Liquid Protein Calibrators, IT2691, to reference material NISBC 19/118. The calibrators lots 2112IT-2116IT, packed into batches 627222, 627224, 634886 and 634887 have been reassigned as part of the restandardization. Following this restandardization, Ferritin results for Quality Control material and patient samples recovered erroneously higher than the targeted calibrator values by approximately +10% across the assay range following.
Distribution
CA, FL, IL, ME, MI, NC, OH, PA,NJ,
Initiated
Voluntary: Firm initiated
Recall number
Z-2448-2023

Ongoing Class II Medical devices

Recall started
21 June 2023
Reason
(1) There is vial to vial variation resulting in some vials recovering positive for hCG, which should be negative and (2) high and outside range for cortisol. (3) There has been a transcription error for Creatinine in the Instructions For Use (IFU). The target and ranges for Creatinine for the Roche Creatinine Plus method have been listed incorrectly. These failures cause a delay in patient results for the above mentioned analytes.
Distribution
Worldwide distribution - US Nationwide distribution in the states of AR, FL, GA, OH, VA including PR and WW distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-2446-2023

Ongoing Class II Medical devices

Recall started
13 June 2023
Reason
Carryover from the Direct LDL-cholesterol assay on the Rx instruments may result in a negative bias, up to -11%, in quality control and patient samples, in urea assays results if the urea assay is run immediately after the Direct LDL-cholesterol assay. This may lead to a delay in reporting results or in falsely decreased urea test results.
Distribution
US Nationwide distribution in the states of CA, DC, GA, OH, OK, MN, MO, NJ, VA and Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall number
Z-2362-2023

Ongoing Class III Medical devices

Recall started
4 May 2023
Reason
Delay in reporting results due to Quality Controls running high outside of range. Target value and range for ACTH in Immunoassay Premium Level 3, IA2640, lot 2031EC and Immunoassay Premium Control Tri Level kit batch 583135 lot 2031EC has been reassigned on the Roche Cobas e801 due to High recovery outside range
Distribution
CA, IL, VA, WA, WI including PR
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2021-2023, Z-2022-2023

Ongoing Class II Medical devices

Recall started
1 February 2023
Reason
The Antibody (R2 reagent) is showing a positive bias compared to previous batches on patient samples. Quality Controls do not show the same bias and will be within range
Distribution
PA, OH, WV
Initiated
Voluntary: Firm initiated
Recall number
Z-1286-2023

Ongoing Class II Medical devices

Recall started
22 November 2022
Reason
Concentration of Rheumatoid Factor has decreased in Specific Protein Control Level 1-3 causing delay in reporting results due to Quality Controls running low outside range
Distribution
US Nationwide distribution in the states of CA, FL, OH,ME, MO, NC, NJ, PA, TN.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0904-2023, Z-0903-2023, Z-0905-2023

Terminated Class II Medical devices

Recall started
1 November 2022
Terminated
18 June 2024
Reason
Update to the carryover avoidance technical bulletin to detail that IgA and IgM assays should not be run immediately after Fructosamine Catalogue Number FR3133 or FR4030 on the RX instruments testing order. Can lead to an elevation in Quality Control and Patient results of up to +13% for lgA and +51% for lgM respectively, which may lead to a delay in running patient samples or erroneous elevated test results
Distribution
US Nationwide Distribution: CA, NC, NJ and WV,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0363-2023, Z-0362-2023

Terminated Class II Medical devices

Recall started
1 August 2022
Terminated
13 December 2024
Reason
***Update** :HBsAg analyte is also Non-Reactive on the Ortho Vitros analyser as well as the Beckman Coulter DxI. Randox Serology I Positive Control will test negative (Non-Reactive) for Marker HBsAg resulting in delay in reporting patient results due to the positive control O36SR testing negative (Non-Reactive) for Marker HBsAg
Distribution
US Nationwide distribution in the states of WV, NC.
Initiated
Voluntary: Firm initiated
Recall number
Z-1772-2022

Terminated Class II Medical devices

Recall started
22 June 2022
Terminated
10 May 2024
Reason
Product fails to meet the performance claims quoted on the kit insert: Manual Procedure when calibrating using the standard provided in the kit, the change in absorbance is lower than expected generating internal quality control results high outside range; Cholesterol (CHOL) Instrument Specific Application using the recommended calibration material CAL2351, the product fails to meet its linearity performance claim quoted on the kit inserts. The linearity is reduced by up to -35% however Quality Control results will still fall within assigned ranges. This may lead to delayed results.
Distribution
Nationwide Distribution - MD, OR, PR, MT, WV
Initiated
Voluntary: Firm initiated
Recall number
Z-1424-2022

Terminated Class III Medical devices

Recall started
9 June 2022
Terminated
8 February 2024
Reason
A customer reported a problem with the reagent and calibrator. Randox Laboratories carried out an investigation and confirmed the issue. The complaint is pertaining to atypical calibration curves that can results in non-numerical results. This affects Siemens Atellica CH analysers only. Customer have reported an atypical calibration curve that results in the values around the low QC range to produce a non-numerical result. It appears to be related to the bottle values of the calibrator producing a curve shape that is too linear for the logitlog calculation to calculate. This issue can only be identified in the Atellica graphical view of the calibration. In most of the cases when this has occurred, it is picked up by the QC generating a Math Error, however, there are reports of QC shifts after calibration without the Math Error flagged that may be related to this issue. Results reported with STFR Level 1, with a concentration less than 1.7mg/L, using TF10159 and TF10161 can be underestimated by up to 30%. This issue has been reported with reagent lots 575475 and 562691, calibrator lots 537725 and 562696. No other complaints received.
Distribution
US Nationwide distribution in the state of IL.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1422-2022, Z-1423-2022

Terminated Class III Medical devices

Recall started
25 March 2022
Terminated
26 December 2023
Reason
Randox have realigned CK-MB Calibrator, CK2393, lot number 4410CK. Calibrating with the new value will cause a positive shift of approximately 6% with both Quality Controls and Patient Samples.
Distribution
Domestic distribution to WV and PR. International distribution to Bangladesh, Bosnia & Herzegovina, Botswana, China, Colombia, Costa Rica, Croatia, Egypt, Fiji, France, Georgia, Germany, Ghana, Greece, Grenada, Hong Kong, India, Iraq, Italy, Lithuania, Malaysia, Maldives, Malta, Mexico, Morocco, Moz
Initiated
Voluntary: Firm initiated
Recall number
Z-1097-2022

Terminated Class II Medical devices

Recall started
1 November 2021
Terminated
9 March 2023
Reason
When calibrating using the standard provided in the kit, the change in absorbance is lower than expected generating internal quality control results high outside range
Distribution
US Nationwide distribution in the states of GA, OR, PA ,WA, West Virginia.
Initiated
Voluntary: Firm initiated
Recall number
Z-0328-2022

Terminated Class II Medical devices

Recall started
10 May 2021
Terminated
10 November 2021
Reason
Standard packed within NEFA kit has been assigned incorrectly. Calibrating with the incorrect value will cause a positive shift of up to +8% with both quality controls and patient samples
Distribution
US Nationwide Distribution in the states of AR, CA, CT, NY, OH, PA, TN, and TX
Initiated
Voluntary: Firm initiated
Recall number
Z-2099-2021

Terminated Class II Medical devices

Recall started
28 April 2021
Terminated
3 December 2021
Reason
An issue was identified where the software froze during processing of commands, which resulted in no results displayed.
Distribution
US Nationwide Distribution and Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall number
Z-2013-2021

Terminated Class II Medical devices

Recall started
29 March 2021
Terminated
22 November 2021
Reason
Randox can confirm a positive bias for Total Bilirubin and Direct Bilirubin of up to +15% across the assay ranges when using calibrator CAL2351, lot 1162UE. The positive bias has been attributed to bilirubin instability in the calibrator and is evident in both Quality Control (QC) and Patient samples.
Distribution
Domestic: IN, MA, CA, NJ, TX, NE, NY, VA, MD, MN, OR, IL, CT, DC, MS. Foreign: Albania, Argentina, Australia, Bangladesh, Bolivia, Bosnia & Herzegovina, Cameroon, Canada, Colombia, Cyprus, Denmark, Egypt, Estonia, Fiji, France, Germany, Greece, Hong Kong, Iraq, Italy, Ireland, Jordan, Kazakhstan, Ke
Initiated
Voluntary: Firm initiated
Recall number
Z-1563-2021

Terminated Class II Medical devices

Recall started
13 November 2020
Terminated
1 April 2021
Reason
Failing to meet the linearity performance claims quoted on the kit inserts-The linearity is reduced by approximately -30% for Serum/ Plasma and -50% for Urine
Distribution
US Nationwide distribution in the states of GA, NJ.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0546-2021, Z-0547-2021

Terminated Class II Medical devices

Recall started
11 August 2020
Terminated
15 October 2020
Reason
An update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover avoidance with the Lactate Dehydrogenase assay on RX Instruments. Additional pipette washes can be implemented as described in the technical bulletin. Interference to the Lactate Dehydrogenase (LOH) reagent would be observed as inconsistencies in Quality Control recovery, which may lead to a delay in running patient samples, or erroneous elevated test results.
Distribution
US Nationwide distribution including in the states of WV, and Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2963-2020, Z-2962-2020

Terminated Class II Medical devices

Recall started
30 July 2020
Terminated
3 February 2021
Reason
Randox Ammonia reagents are being recalled from the field due to a positive bias of up to 140¿mol/l being observed on patient samples.
Distribution
US Distribution to states of: VA, UT, WV and country of : Canada
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2965-2020, Z-2966-2020

Terminated Class II Medical devices

Recall started
10 July 2020
Terminated
17 June 2021
Reason
Amylase AY3805 batch 480449 and Pancreatic Amylase AY3855 batch 480483 have failed to meet the quoted performance claims prior to expiry on 28th Sept 2020.
Distribution
New Mexico, Massachusetts, WV. Foreign distribution to Bolivia BOSNIA AND HERZEGOVINA Brazil Colombia Costa Rica Cyprus Egypt France Greece Grenada India Iraq Italy Jordan Kazakhstan Kenya Lithuania Mauritius Nepal Nigeria Pakistan Peru Philippines Poland Portugal Qa
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2923-2020, Z-2924-2020

Terminated Class II Medical devices

Recall started
26 June 2020
Terminated
19 October 2020
Reason
Randox have confirmed imprecision of quality control and patient samples when using specific Randox Lipase R2 Substrate batches.
Distribution
Worldwide distribution - US Nationwide distribution including in the states of Puerto Rico and WV.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2753-2020, Z-2752-2020, Z-2751-2020

Ongoing Class II Medical devices

Recall started
18 February 2020
Reason
The control target and range value for Sodium using the ISE indirect method has been assigned incorrectly.
Distribution
Worldwide distribution - US Nationwide distribution in the states of WV, IN, VA, ID, PR, DE, and countries of West Indies, Czech Republic, France, Germany, Hong Kong, Ireland, Italy, Norway, Philippines, South Africa, South Korea, Sweden, Taiwan (R.O.C.), Thailand, UAE, UK.
Initiated
Voluntary: Firm initiated
Recall number
Z-1547-2020

Terminated Class II Medical devices

Recall started
19 December 2019
Terminated
23 April 2021
Reason
Software version UI2550642107 for the RX Daytona + instrument released to correct the following issues: 1) The order of samples displayed is not sequential according to SID (sample identification number) when searching the run/results screen; 2) Incorrect color flagging of IQC as "out of range."
Distribution
US Nationwide distribution including state of PR.
Initiated
Voluntary: Firm initiated
Recall number
Z-1349-2020

Terminated Class III Medical devices

Recall started
13 December 2019
Terminated
2 October 2020
Reason
A transcription error has occurred for the Randox Lipase colorimetric value in Liquid Clinical Chemistry Control lot 1021 UE. The target and range are listed as 50 U/L (40 - 60) and should be 72U/L (58 - 86).
Distribution
US: NY and DE OUS: France, Lithuania, Poland, Spain, Switzerland, Turkey, Australia, Hong Kong, Bosnia and Herzegovina, Costa Rica, Ecuador, Gambia, New Zealand and Solomon Islands.
Initiated
Voluntary: Firm initiated
Recall number
Z-1100-2020

Terminated Class II Medical devices

Recall started
4 October 2019
Terminated
6 July 2020
Reason
Removal of claims for N-proBNP in the Liquid Cardiac Control catalogue number CQ5053 due to an observed decrease in recovery for N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in recent lots.
Distribution
US Distribution: WV, CA, DE, NJ, NY, GA, IN, PR OUS Distribution: CA, PL, CH, JP, NL, IT, CN, GB, IE, RU, MD, BY, SA, VN, AE, BH, DK, CO, ES, FR, TW, PH, TH, OM, HU, IN, KR, ZA, AU, CZ, PE, CL, IR, NZ, BE, DE, BA, SV, SK, HK, PT, PK, BR, TR, UA, SE, QA, LT, PE,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0414-2020, Z-0412-2020, Z-0413-2020

Terminated Class III Medical devices

Recall started
23 September 2019
Terminated
7 May 2020
Reason
Non-Esterified Fatty Acids (NEFA) FA115 batch 485343 is not meeting the performance claims and should not be used in any further testing.
Distribution
WV (USA), International: GB, BE, CZ, FR, GR, IE, IT, NL, PL, SK, ES, CH, TR, AU, BR, MX, RU, SG, TW
Initiated
Voluntary: Firm initiated
Recall number
Z-0367-2020

Terminated Class II Medical devices

Recall started
9 August 2019
Terminated
8 January 2021
Reason
The assigned value for Rheumatoid Factor over recovers against the reference material RF serum, 1st British standard from NIBSC. Ref = 64/002. The calibrator values have been adjusted to re-align to the reference material.
Distribution
US Nationwide distribution in the states of WV, ME, NJ, CA, and Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0283-2020, Z-0282-2020

Terminated Class III Medical devices

Recall started
25 July 2019
Terminated
3 December 2020
Reason
Analyte range for Leukocytes for use with the Siemens Multistix method is incorrect. The range was corrected to NEGATIVE to 3+.
Distribution
US Nationwide distribution including the states of IN, WV.
Initiated
Voluntary: Firm initiated
Recall number
Z-2557-2019

Terminated Class III Medical devices

Recall started
12 July 2019
Terminated
17 June 2020
Reason
Randox Laboratories realigned RX Analyser Series calibration targets by 10% for AST and 9% for ALT in line with the Mean of All Instrument method target for the Randox Calibration Serum Level 3 (for calibrator lot 961UE onwards).
Distribution
Nationwide Foreign: Antigua, Aruba, Bahamas, Granada, Tobago,
Initiated
Voluntary: Firm initiated
Recall number
Z-2490-2019

Terminated Class II Medical devices

Recall started
24 June 2019
Terminated
21 May 2020
Reason
There was a report of a malfunction with the sensor which resulted in an increase of temperature leading to melting of internal wires and scorch damage to the internal structure of the instrument.
Distribution
Domestic distribution to CA CT MA MD MO NC NJ NY OH PA UT WV and PR. Worldwide foreign distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2083-2019, Z-2084-2019

Terminated Class II Medical devices

Recall started
11 June 2019
Terminated
15 May 2020
Reason
The RX Series control target and range value for ALT (Tris buffer without P5P 37C), Bicarbonate and Gamma-GT has been incorrectly assigned in specific lots of the Human Assayed Multi-Sera Controls.
Distribution
US Nationwide Distribution - AZ CA CT FL GA IL KY LA MA MD MI MN MO NJ NY OH OK OR PA TX UT VA WA WI WV and PR. Worldwide foreign distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-2150-2019

Terminated Class III Medical devices

Recall started
10 June 2019
Terminated
16 June 2020
Reason
The firm is re-assigning the Mean of all Instruments target and range for Bile Acids (5th Generation Colorimetric) in the Assayed Bovine Multi-Sera Level 1 Control Lot 205SL.
Distribution
Domestic distribution to Arizona, Oregon, Washington, and West Virginia. Foreign distribution to Australia, Belarus, Canada, France, Germany, Ireland, Kenya, Korea, Lithuania, New Zealand, Nigeria, Oman, Russia, Singapore, South Africa, Sweden, Switzerland, Turkey, and UK.
Initiated
Voluntary: Firm initiated
Recall number
Z-2207-2019

Terminated Class II Medical devices

Recall started
3 April 2019
Terminated
9 October 2019
Reason
The target values and ranges in these lots are incorrect.
Distribution
The products were distributed to the following US states: IL, OH, NC, PA, WI, WV and Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1255-2019, Z-1254-2019

Terminated Class II Medical devices

Recall started
11 March 2019
Terminated
15 May 2020
Reason
Customers may observe a decrease in recovered concentration with regards to NTproBNP in the Liquid Cardiac Control lots identified, on the Siemens Dimension EXL LOCI.
Distribution
Product distributed to CA, DE, WV, and Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall number
Z-1785-2019

Terminated Class II Medical devices

Recall started
13 February 2019
Terminated
14 April 2020
Reason
An error in the assignment of the control range pH in Blood Gas Control
Distribution
US Distribution to state of: WV
Initiated
Voluntary: Firm initiated
Recall number
Z-1057-2019

Terminated Class III Medical devices

Recall started
7 February 2019
Terminated
8 June 2020
Reason
The target value for uptake is incorrect on the value sheet for an analyzer. The target value for this analyzer is listed as 43.8%U and should be 39.4%U.
Distribution
The products were distributed to the following US states: WV and Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1107-2019, Z-1105-2019, Z-1106-2019

Terminated Class II Medical devices

Recall started
4 December 2018
Terminated
18 June 2020
Reason
Update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover avoidance with the Calcium assay on RX instruments. Carryover to the Calcium reagent results may result in falsely elevated or decreased results to both patient and QC samples.
Distribution
WV, PR
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0839-2019, Z-0840-2019

Ongoing Class II Medical devices

Recall started
3 December 2018
Reason
The firm is conducting a Device Modification for Fructosamine Calibrator, Fructosamine Control 1 and Control 3 for the lots specified. The assigned value of Fructosamine in this calibrator and controls has now been re-assigned by a decrease of 25%.
Distribution
US Distribution to states to: CA, ME. MI, and WV.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1018-2019, Z-1016-2019, Z-1017-2019

Terminated Class II Medical devices

Recall started
19 November 2018
Terminated
23 April 2020
Reason
Calibrator value sheets have been modified for assigned value of Alpha-1-Acid-Glycoprotein (AGP), IgA and IgG to improve the alignment. IgG measurement reference has also been corrected.
Distribution
US Distribution to states of : IN, NJ, NY, TX and WV and internationally to Ireland.
Initiated
Voluntary: Firm initiated
Recall number
Z-0660-2019

Terminated Class II Medical devices

Recall started
2 October 2018
Terminated
30 May 2019
Reason
Randox has previously issued a recall for Liquid Cardiac Control CQ5053 lot 4245CK under REC334 on June 8, 2018. The firm has now confirmed the Liquid Cardiac Controls CQ5051, CQ5052 and CQ5053 are no longer suitable for the control of the Troponin T assay due to unacceptable variation between vials.
Distribution
Distributed to IN, NY, PR, and WV.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0382-2019, Z-0381-2019, Z-0380-2019

Terminated Class II Medical devices

Recall started
8 June 2018
Terminated
5 November 2018
Reason
The device is not suitable for the control of the Troponin T assay due to unacceptable variation between vials. The deviation in precision observed is up to 28%. IQC that is reported as out of range could lead to a delay in reporting Troponin T results. If the failure occurs the operator may observe the quality control result for Troponin T falling outside range and/or increased imprecision for Quality Control monitoring.
Distribution
Worldwide Distribution - US in the state of WV. Foreign distribution to Australia, Chile, China, Germany, Hungary, Ireland, Italy, Moldova, Netherlands, Peru, Poland, Saudi Arabia, Slovakia, Spain, Sultanate of Oman, UAE, UK, and Vietnam
Initiated
Voluntary: Firm initiated
Recall number
Z-2575-2018

Terminated Class II Medical devices

Recall started
22 May 2018
Terminated
17 November 2020
Reason
The recalling firm has confirmed that Free Kappa light chains in Liquid Assayed Specific Protein Controls increase over the shelf life of the product. This may lead to a delay in reporting Free Kappa Light Chains results, which are used as an aid in diagnosis of monoclonal gammopathy of undetermined significance and for Multiple Myeloma through review of the ratio with free lambda chains.
Distribution
Distributed to accounts in CA, IN, KS, ME, and WV, and PR. Foreign distribution to Australia, Bangladesh, Belarus, Belgium, Brazil, Cambodia, Canada, Chile, China, Colombia, Cyprus, Denmark, Dutch Caribbean, Ecuador, Egypt, El Salvador, Ethiopia, Falkland Islands, Finland, France, Georgia, Germany,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2279-2018, Z-2278-2018, Z-2280-2018

Terminated Class II Medical devices

Recall started
4 May 2018
Terminated
16 June 2020
Reason
Abnormal premature termination of the software could affect the use of the analyser when running patient samples. The impact being a delay in reporting test results.
Distribution
US Distribution including Puerto Rico and the state of : West Virginia.
Initiated
Voluntary: Firm initiated
Recall number
Z-2059-2018

Terminated Class II Medical devices

Recall started
2 March 2018
Terminated
11 April 2019
Reason
Randox has now released further steps to avoid contamination of the Lipase Assay on Rx instruments.
Distribution
US Nationwide Distribution in the states of West Virginia and Puerto Rico
Initiated
Voluntary: Firm initiated
Recall number
Z-1631-2018

Terminated Class III Medical devices

Recall started
11 August 2017
Terminated
29 March 2019
Reason
The ACTH in Immunoassay Premium and Premium Plus quality control does not meet the quoted reconstituted stability claim in the product IFU.
Distribution
Distribution US nationwide.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0969-2018, Z-0970-2018

Terminated Class II Medical devices

Recall started
8 August 2017
Terminated
5 September 2018
Reason
Randox has confirmed that Troponin T and Troponin I in Liquid Cardiac quality control CQ5053 lot 4069CK does not meet the shelf-life claim in the product labelling. As the control may now fall outside the provided control ranges the product is to be recalled from the field.
Distribution
Nationally
Initiated
Voluntary: Firm initiated
Recall number
Z-0937-2018

Terminated Class II Medical devices

Recall started
7 June 2017
Terminated
2 July 2018
Reason
Randox confirmed low calibration absorbance with HbA1c, Catalog Number HA3830, Batch 414553. The reagent may not continue to meet its specific performance characteristics throughout the shelf life of the product.
Distribution
Puerto Rico; International: Portugal, Italy, Turkey, Slovakia, Russia, Thailand and Vietnam
Initiated
Voluntary: Firm initiated
Recall number
Z-0285-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.